Locke Lord Team Represented Rapid Genomics in Sale to LGC

A Locke Lord team represented Rapid Genomics, a provider of mid-to high-density Next-Generation Sequencing kits and services for genotyping, in its sale to LGC, Biosearch Technologies (LGC). LGC is a leading, global life science tools company, providing components and solutions into high-growth application areas across the human health care and applied market segments. This acquisition will enable future growth and development of LGC’s Next-Generation Sequencing high-throughput offerings in the agrigenomics space. For more information, see the press release. Additional assistance was provided by John Igoe and Gil Greber (both of West Palm Beach), Michael Bennett and Kanasha Herbert (both of Chicago), and Christopher Flanagan and Gene Schlack (both of Boston).
Posted on April 5, 2022